File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study

TitlePharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
Authors
Gupta, NGoh, YTMin, CKLee, JHKim, KWong, RSMChim, JCSHanley, MJYang, HVenkatakrishnan, KHui, AMEsseltine, DLChng, WJ
KeywordsEast Asian
Ethnicity
Ixazomib
Multiple myeloma
Pharmacokinetics
Issue Date2015
PublisherBioMed Central Ltd. The Journal's web site is located at http://www.jhoonline.org
Citation
Journal of Hematology & Oncology, 2015, v. 8, article no. 103 How to Cite?
DOI: http://dx.doi.org/10.1186/s13045-015-0198-1
Persistent Identifierhttp://hdl.handle.net/10722/214303
ISSN
1756-8722
2023 Impact Factor: 29.5
2023 SCImago Journal Rankings: 7.522
PubMed Central ID
PMC4559079
ISI Accession Number ID
WOS:000361364400001

 

DC FieldValueLanguage
dc.contributor.authorGupta, N-
dc.contributor.authorGoh, YT-
dc.contributor.authorMin, CK-
dc.contributor.authorLee, JH-
dc.contributor.authorKim, K-
dc.contributor.authorWong, RSM-
dc.contributor.authorChim, JCS-
dc.contributor.authorHanley, MJ-
dc.contributor.authorYang, H-
dc.contributor.authorVenkatakrishnan, K-
dc.contributor.authorHui, AM-
dc.contributor.authorEsseltine, DL-
dc.contributor.authorChng, WJ-
dc.date.accessioned2015-08-21T11:10:52Z-
dc.date.available2015-08-21T11:10:52Z-
dc.date.issued2015-
dc.identifier.citationJournal of Hematology & Oncology, 2015, v. 8, article no. 103-
dc.identifier.issn1756-8722-
dc.identifier.urihttp://hdl.handle.net/10722/214303-
dc.languageeng-
dc.publisherBioMed Central Ltd. The Journal's web site is located at http://www.jhoonline.org-
dc.relation.ispartofJournal of Hematology & Oncology-
dc.rightsJournal of Hematology & Oncology. Copyright © BioMed Central Ltd.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectEast Asian-
dc.subjectEthnicity-
dc.subjectIxazomib-
dc.subjectMultiple myeloma-
dc.subjectPharmacokinetics-
dc.titlePharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study-
dc.typeArticle-
dc.identifier.emailChim, JCS: jcschim@hku.hk-
dc.identifier.authorityChim, JCS=rp00408-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/s13045-015-0198-1-
dc.identifier.pmid26337806-
dc.identifier.pmcidPMC4559079-
dc.identifier.scopuseid_2-s2.0-84940658248-
dc.identifier.hkuros246242-
dc.identifier.volume8-
dc.identifier.isiWOS:000361364400001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl1756-8722-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats